Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial

Published:2011-12 Issue:1 Volume:12 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Lips Irene M,van der Heide Uulke A,Haustermans Karin,van Lin Emile NJT,Pos Floris,Franken Stefan PG,Kotte Alexis NTJ,van Gils Carla H,van Vulpen Marco

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/article/10.1186/1745-6215-12-255/fulltext.html

Reference74 articles.

1. Lu-Yao GL, Yao SL: Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet. 1997, 349 (9056): 906-910.

2. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002, 53 (5): 1097-1105.

3. Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fossa SD, Scandinavian Prostate Cancer Group Study 7, Swedish Association for Urological Oncology 3: Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009, 373 (9660): 301-308.

4. Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, Bonfrer JM, Incrocci L, Lebesque JV: Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol. 2006, 24 (13): 1990-1996.

5. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ, Miller DW, Adams JA, Shipley WU: Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005, 294 (10): 1233-1239.

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Part I: prostate cancer detection, artificial intelligence for prostate cancer and how we measure diagnostic performance: a comprehensive review;Current Problems in Diagnostic Radiology;2024-09

2. Stereotactic Body Radiation Therapy (SBRT) in prostate cancer in the presence of hip prosthesis – is it a contraindication? A narrative review;BMC Urology;2024-07-26

3. Using multiparametric Magnetic Resonance Imaging and Prostate Specific Membrane Antigen Positron Emission Tomography to detect and delineate the gross tumour volume of intraprostatic lesions – A systematic review and meta-analysis;Radiotherapy and Oncology;2024-03

4. Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient‐specific or population‐based biological features;Medical Physics;2024-01-15

5. Focal Boost in Prostate Cancer Radiotherapy: A Review of Planning Studies and Clinical Trials;Cancers;2023-10-08